Over ten years of research and development at Bascome Palmer Eye Institute; ranked #1 in the US for ophthalmology.
Bascom Palmer is ranked the number one eye hospital in the U.S., and where our AI-driven diagnostics and vision augmentation platform is continuously developed.
Our technology is the culmination of over ten years of clinical and scientific research and development. This effort is led by Heru’s Founder and CEO Mohamed Abou Shousha, MD, PhD, associate professor of clinical ophthalmology, Bascom Palmer Eye Institute.
After years of feeling limited by options to help improve his patients’ lives, Dr. Abou Shousha became inspired and he and his team of leading physicians, scientists and engineers set out to develop Heru’s artificial intelligence (AI) powered wearable device.
Founder, President, and Chief Executive Officer
Mohamed Abou Shousha, MD, PhD is Heru’s President and Chief Executive Officer. Dr. Abou Shousha is a practicing Opthamologist at the University of Bascom Palmer Eye Institute, where he serves as Associate Professor of Clinical Opthamology, Electrical and Computer Engineering, and Biomedical Engineering.
Chairman of the Board
Maurice R. Ferré, MD is a seasoned serial entrepreneur in the medical technology industry. Dr. Ferré is currently Chief Executive Officer and Chairman of the Board at INSIGHTEC, the innovator of incisionless surgery. Prior to this, Dr. Ferré served as Chief Executive Officer and Chairman of the Board of MAKO Surgical Corporation, a robotic surgical company that he co-founded.
Richard K. Parrish II, MD is a world-renown glaucoma specialist and is the Edward W.D. Norton Chair in Ophthalmology and Associate Dean for Graduate Medical Education ot the University of Miami Miller School of Medicine. he also serves as Chairman of the Graduate Medical Education Committee and is the designated institutional representative for the Jackson Health System/Jackson Memorial Hospital.
Fred Drasner is presently Chairman of the Three Seasons Capital, LLC, a venture capital firm. Mr. Drasner joined Shaw, Pittman, Potts, and Trowbridge (now Pillsbury Winthrop Shaw Pittman) in 1972 as a tax lawyer and served as its principal Tax Partner until 1985. In 1985, Mr. Drasner, with a partner, acquired U.S. News & World Report and served as its CEO and Co-Chairman from 1985 to 2004.
Rajesh Rajpal, MD is the Founder of See Clearly Vision, a group practice in the Washington, D.C. Area. He previously served as Chief Medical Officer for Avedro (acquired by Glaukos) and is Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision.
Kerri-Lynn is currently the Chief Technology Officer for Healthcare and Life Sciences for Microsoft Industry Solutions. She serves as an advisor in the Mixed Reality and connected IoT space and is passionate about AR/VR/MR and IoT’s potential to healthcare. Kerri-Lynn also previously held an executive role at Kaiser Permanente focused on driving the success of transformational programs.
SoftBank’s SB Opportunity Fund is a $100 million venture fund. SoftBank Group Corp. is a Japanese multinational conglomerate holding company headquartered in Minato, Tokyo. The Group primarily invests in companies operating in the technology, energy, and financial sectors.
Chairman of Three Seasons Capital, LLC
Chief Executive Officer and Chairman, INSIGHTEC
Partner, Ceros Financial Services
Chief Development Officer, Johnson and Johnson Medical Devices Companies
President, UIA Management
Managing Partner, VH Properties and Director, Virgin Hotels
Jeffrey Miller, managing partner
Melissa Krinzman, managing partner